NCT07321574 2026-01-07
ABP1011T-03
Shanghai AB PharmaTech Ltd.
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06812260 2025-09-17
A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC
Shanghai Henlius Biotech
Phase 2 Recruiting
NCT04221529 2025-09-08
SPACE
AIO-Studien-gGmbH
Phase 2 Completed
NCT06793228 2025-01-27
Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT06768307 2025-01-10
Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT06620796 2024-10-01
A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting